Astellas Resolves Adenoscan Disputes With Teva
Monday’s agreement allows Teva to market and sell its generic version of the drug under a license in September 2012.
Teva’s abbreviated new drug application for a generic copy of Adenoscan triggered the pair of lawsuits in May 2005 in the U.S. District Court for the District of Delaware. Astellas sued Teva along with co-plaintiffs...
To view the full article, register now.